Colitis: Clinical Trials

1,905 trials for Colitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

878 completed, 269 unknown, 262 recruiting, 188 terminated. 441 Not applicable, 366 Phase 2, 240 Phase 3, 193 Phase 1, 130 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable441Completed 186, Unknown 83, Recruiting 65, Terminated 39, Not yet recruiting 33, Active not recruiting 14, Withdrawn 11, Enrolling by invitation 7, Suspended 3
Phase 2366Completed 158, Terminated 62, Recruiting 57, Unknown 34, Active not recruiting 23, Withdrawn 18, Not yet recruiting 11, Enrolling by invitation 3
Phase 3240Completed 133, Terminated 32, Unknown 25, Recruiting 22, Active not recruiting 18, Withdrawn 6, Not yet recruiting 3, Enrolling by invitation 1
Phase 1193Completed 101, Terminated 25, Recruiting 19, Unknown 19, Not yet recruiting 14, Active not recruiting 6, Withdrawn 6, Enrolling by invitation 3
Phase 4130Completed 57, Unknown 17, Recruiting 15, Terminated 15, Not yet recruiting 14, Withdrawn 6, Active not recruiting 3, Enrolling by invitation 3
Early Phase 121Unknown 8, Not yet recruiting 4, Completed 2, Recruiting 2, Terminated 2, Withdrawn 2, Enrolling by invitation 1

Follow Colitis: new trials by email Literature Review of Colitis trials Research Report on Colitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis
High dose budesonide rectal foam, Low dose budesonide rectal foam, Matching placebo rectal foam - Ulcerative Colitis
Phase 4Not yet recruitingBausch Health Americas, Inc.1002029-06-012026-10-06
ACT for Veterans With IBD and Mental Health Challenges
Acceptance and Commitment Therapy - Inflammatory Bowel Diseases, Crohn's Disease
Not applicableNot yet recruitingVA Office of Research and Development502028-01-012026-02-09
A Mindfulness-based Stress Reduction Program for IBD
Mindfulness based stress reduction, Active Control - Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)
Not applicableNot yet recruitingNova Scotia Health Authority702027-09-012026-09-08
Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease
Digital Mind Body Intervention mobile application - Crohn's Disease, Ulcerative Colitis
Not applicableNot yet recruitingMontefiore Medical Center402027-07-012026-11-16
Adapted Physical Activity for Persistent Fatigue in Patients With Inflammatory Bowel Disease in Remission
Adapted Physical Activity, Usual Care - Inflammatory Bowel Diseases (IBD), Fatigue
Not applicableNot yet recruitingUniversity Hospital, Grenoble1202027-06-012026-09-11
ASAPP Study - Topical 5-ASA as Prophylaxis for Pouchitis in Ulcerative Colitis Patients After Pelvic Pouch Surgery
5-ASA, Placebo - Ulcerative Colitis (UC), Pouchitis
Phase 4Not yet recruitingUniversity Hospital, Linkoeping1102027-04-012026-08-19
LMT503 First-in-human SAD, MAD, and FE Study
LMT503, Placebo - Inflammatory Bowel Disease, Colitis, Ulcerative
Phase 1Not yet recruitingLmito Therapeutics Inc.722027-03-012026-09-01
Efficacy and Safety of TRA16 Administered Orally in Patients With Enteric Hyperoxaluria (EH).
TRA16, Placebo - Enteric Hyperoxaluria
Phase 2Not yet recruitingWuhan Kangfude Urolithiasis Research Institute Co., Ltd.302027-03-012026-10-13
Oral Aeromonas sp. MTB Phage Therapy for Pouchitis in Patients With Ulcerative Colitis (UC)
MTB-targeted phage therapy - Pouchitis, UC - Ulcerative Colitis
Early Phase 1Not yet recruitingJinling Hospital, China122027-01-012026-10-22
Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK Inhibitors in Deep Remission Patients With Ulcerative Colitis
treatment withdrawal - Ulcerative Colitis in Remission
Phase 4Not yet recruitingAssistance Publique Hopitaux De Marseille2242027-01-012026-11-10
Safety, Tolerability and PK of ATTO 1091 in Healthy Adult Volunteers and Patients With Ulcerative Colitis
ATTO-1091, Placebo - Ulcerative Colitis (UC)
Phase 1Not yet recruitingAttovia Therapeutics Inc962026-12-142026-09-15
The EDICT Trial - Therapy for Inflammatory Bowel Disease Flares
elemental diet (ED) - Inflammatory Bowel Disease
Not applicableNot yet recruitingWake Forest University Health Sciences422026-12-012026-09-28
FirST Lines of Biologics in pAtients With ulceRaTivE Colitis: a Randomised Controlled Trial
1: infliximab 2: filgotinib 3: ustekinumab 4: vedolizumab, 1: ustekinumab 2: vedolizumab 3: infliximab 4: filgotinib, 1: vedolizumab 2: infliximab 3: filgotinib 4: ustekinumab - Ulcerative Colitis (UC)
Phase 4Not yet recruitingUniversity Hospital, Clermont-Ferrand2402026-12-012026-10-21
Non-Invasive Biomarker Monitoring in UC on Biologics
Ulcerative Colitis
Not yet recruitingUniversity Hospitals Coventry and Warwickshire NHS Trust992026-11-182026-11-05
A Real-World Study of Guselkumab Persistence and Effectiveness in Participants With Crohn's Disease or Ulcerative Colitis
Colitis, Ulcerative, Crohn Disease
Not yet recruitingJanssen-Cilag, S.A.2002026-11-152026-11-03
Efficacy of Upadacitinib Re-induction Therapy in Patients With Ulcerative Colitis Who Lost Response to 30 mg Maintenance Dose
Upadacitinib - Ulcerative Colitis (UC)
Phase 4Not yet recruitingGroupe d'Etude Therapeutique des Affections Inflammatoires Digestives1002026-11-152026-10-29
A Study of Continued Use of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting
Crohn Disease, Colitis, Ulcerative
Not yet recruitingJanssen Sciences Ireland UC352026-11-122026-11-03
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Inflammatory Bowel Disease, Crohn's Disease
RecruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1002026-11-052026-11-10
Microbiome-targeted Diet Therapy in Ulcerative Colitis
High Protein, High Fiber (HPHF) Diet - Ulcerative Colitis
Not applicableRecruitingUniversity of Minnesota402026-11-042026-11-09
An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 Substrates
Duvakitug - Ulcerative Colitis, Crohn's Disease
Phase 1Not yet recruitingSanofi252026-11-032026-11-06

Showing 20 of 1905. Sign in to see all of them.

Narrower conditions

Colitis, Ulcerative (1801)  ·  Crohn Disease (682)  ·  Inflammatory Bowel Diseases (643)  ·  Arthritis, Rheumatoid (43)  ·  Irritable Bowel Syndrome (38)  ·  Arthritis, Psoriatic (35)  ·  Colorectal Neoplasms (29)  ·  Gastrointestinal Diseases (29)  ·  Spondylitis, Ankylosing (29)  ·  Ulcer (29)  ·  Psoriasis (27)  ·  Colitis, Microscopic (22)  ·  Pouchitis (22)  ·  Depression (21)

Broader conditions

Gastroenteritis (1894)  ·  Colonic Diseases (1891)  ·  Digestive System Diseases (1886)  ·  Intestinal Diseases (1885)  ·  Gastrointestinal Diseases (1876)  ·  Inflammatory Bowel Diseases (1187)  ·  Pathological Conditions, Signs and Symptoms (175)  ·  Pathologic Processes (109)  ·  Immune System Diseases (87)  ·  Neoplasms (77)  ·  Skin and Connective Tissue Diseases (77)  ·  Musculoskeletal Diseases (73)  ·  Neoplasms by Site (68)  ·  Joint Diseases (66)

Interventions

Mesalamine (88)  ·  vedolizumab (67)  ·  Infliximab (64)  ·  Fecal Microbiota Transplantation (58)  ·  Adalimumab (42)  ·  golimumab (26)  ·  Ustekinumab (20)  ·  Blood Specimen Collection (19)  ·  Budesonide (19)  ·  etrasimod (18)  ·  tofacitinib (18)  ·  mirikizumab (17)  ·  Azathioprine (16)  ·  Colonoscopy (16)  ·  Standard of Care (15)

Sponsors

Takeda (48)  ·  AbbVie (40)  ·  Pfizer (37)  ·  Janssen Research & Development, LLC (27)  ·  Bausch Health Americas, Inc. (18)  ·  Ferring Pharmaceuticals (18)  ·  Mayo Clinic (18)  ·  Bristol-Myers Squibb (17)  ·  Assiut University (16)  ·  Shire (16)  ·  Assistance Publique - Hôpitaux de Paris (14)  ·  Eli Lilly and Company (14)  ·  GlaxoSmithKline (14)  ·  Sanofi (13)  ·  Chinese University of Hong Kong (12)

Countries

United States (637)  ·  Canada (272)  ·  Germany (250)  ·  France (247)  ·  Poland (221)  ·  United Kingdom (216)  ·  Italy (206)  ·  Belgium (187)  ·  Netherlands (169)  ·  China (167)  ·  Hungary (165)  ·  Israel (161)  ·  Spain (157)  ·  Czechia (150)  ·  South Korea (139)

Results publications

PMID 40243391, PMID 40013523, PMID 32445184, PMID 35648151, PMID 36124702, PMID 29850873, PMID 30476584, PMID 31077827, PMID 31599001, PMID 32816215, PMID 33684552, PMID 35792493, PMID 36342120, PMID 36526796, PMID 36931693, PMID 38425446, PMID 39778975, PMID 26893500, PMID 32766762, PMID 32870265, PMID 32964215, PMID 33127596, PMID 33324993, PMID 33513294, PMID 34614208, PMID 35380664, PMID 35380740, PMID 36336750, PMID 37402275, PMID 37560161, PMID 38310565, PMID 38778549, PMID 42248437, PMID 16339095, PMID 19596014, PMID 25173754, PMID 25857665, PMID 26363929, PMID 26563167, PMID 27959607, PMID 28467869, PMID 29028981, PMID 29142515, PMID 29380251, PMID 29409871, PMID 29743836, PMID 29909019, PMID 30721964, PMID 30739254, PMID 31279870

NIH funding

2023 (29), 2017 (24), 2016 (19), 2018 (18), 2025 (17), 2015 (12), 2019 (11), 2014 (9), 2004 (5), 2009 (5), 2008 (4), P30CA060553 (2), U01DK062423 (2), U01DK062431 (2), 1IK2RD000689-01A2 (1)